Purified viral neuraminidase vaccine to control influenza.
Identifieur interne : 000460 ( Pmc/Corpus ); précédent : 000459; suivant : 000461Purified viral neuraminidase vaccine to control influenza.
Auteurs : D J AroraSource :
- Canadian Medical Association Journal [ 0008-4409 ] ; 1979.
Abstract
The control of influenza by immunoprophylaxis is difficult because of the antigenic mutability of the influenza virus and the unpredictability of its epidemiologic behaviour. The inactivated whole-virus vaccine currently used is not ideal. Vaccination with pure neuraminidase is suggested. The induced antineuraminidase antibody will restrict viral invasion. Mild illness may or may not occur. On subsequent exposure to influenza virus the individual will produce antihemagglutinin and antineuraminidase antibodies and will be resistant to both infection and illness. Since antigenic changes are less frequent in the viral neuraminidase than in the viral hemagglutinin, the vaccine would be usable for longer periods than the presently used inactivated whole-virus vaccine.
Url:
PubMed: 394829
PubMed Central: 1704613
Links to Exploration step
PMC:1704613Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Purified viral neuraminidase vaccine to control influenza.</title><author><name sortKey="Arora, D J" sort="Arora, D J" uniqKey="Arora D" first="D J" last="Arora">D J Arora</name></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">394829</idno><idno type="pmc">1704613</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1704613</idno><idno type="RBID">PMC:1704613</idno><date when="1979">1979</date><idno type="wicri:Area/Pmc/Corpus">000460</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000460</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Purified viral neuraminidase vaccine to control influenza.</title><author><name sortKey="Arora, D J" sort="Arora, D J" uniqKey="Arora D" first="D J" last="Arora">D J Arora</name></author></analytic><series><title level="j">Canadian Medical Association Journal</title><idno type="ISSN">0008-4409</idno><imprint><date when="1979">1979</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>The control of influenza by immunoprophylaxis is difficult because of the antigenic mutability of the influenza virus and the unpredictability of its epidemiologic behaviour. The inactivated whole-virus vaccine currently used is not ideal. Vaccination with pure neuraminidase is suggested. The induced antineuraminidase antibody will restrict viral invasion. Mild illness may or may not occur. On subsequent exposure to influenza virus the individual will produce antihemagglutinin and antineuraminidase antibodies and will be resistant to both infection and illness. Since antigenic changes are less frequent in the viral neuraminidase than in the viral hemagglutinin, the vaccine would be usable for longer periods than the presently used inactivated whole-virus vaccine.</p></div></front></TEI><pmc article-type="review-article"><pmc-comment>The publisher of this article does not allow downloading of the full text in XML form.</pmc-comment>
<front><journal-meta><journal-id journal-id-type="nlm-ta">Can Med Assoc J</journal-id><journal-title>Canadian Medical Association Journal</journal-title><issn pub-type="ppub">0008-4409</issn></journal-meta><article-meta><article-id pub-id-type="pmid">394829</article-id><article-id pub-id-type="pmc">1704613</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Purified viral neuraminidase vaccine to control influenza.</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Arora</surname><given-names>D J</given-names></name></contrib></contrib-group><pub-date pub-type="ppub"><day>22</day><month>12</month><year>1979</year></pub-date><volume>121</volume><issue>12</issue><fpage>1575</fpage><lpage>1579</lpage><abstract><p>The control of influenza by immunoprophylaxis is difficult because of the antigenic mutability of the influenza virus and the unpredictability of its epidemiologic behaviour. The inactivated whole-virus vaccine currently used is not ideal. Vaccination with pure neuraminidase is suggested. The induced antineuraminidase antibody will restrict viral invasion. Mild illness may or may not occur. On subsequent exposure to influenza virus the individual will produce antihemagglutinin and antineuraminidase antibodies and will be resistant to both infection and illness. Since antigenic changes are less frequent in the viral neuraminidase than in the viral hemagglutinin, the vaccine would be usable for longer periods than the presently used inactivated whole-virus vaccine.</p></abstract></article-meta></front></pmc></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/H2N2V1/Data/Pmc/Corpus
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000460 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd -nk 000460 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= H2N2V1
|flux= Pmc
|étape= Corpus
|type= RBID
|clé= PMC:1704613
|texte= Purified viral neuraminidase vaccine to control influenza.
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Pmc/Corpus/RBID.i -Sk "pubmed:394829" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Pmc/Corpus/biblio.hfd \
| NlmPubMed2Wicri -a H2N2V1
| This area was generated with Dilib version V0.6.33. |  |